Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.

MLA

Gao, Shan, et al. “Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling.” Cancer Research, vol. 74, no. 20, Oct. 2014, pp. 5866–77. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-14-0806.

APA

Gao, S., Bajrami, I., Verrill, C., Kigozi, A., Ouaret, D., Aleksic, T., Asher, R., Han, C., Allen, P., Bailey, D., Feller, S., Kashima, T., Athanasou, N., Blay, J.-Y., Schmitz, S., Machiels, J.-P., Upile, N., Jones, T. M., Thalmann, G., … Macaulay, V. M. (2014). Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. Cancer Research, 74(20), 5866–5877. https://doi.org/10.1158/0008-5472.CAN-14-0806

Chicago

Gao, Shan, Ilirjana Bajrami, Clare Verrill, Asha Kigozi, Djamila Ouaret, Tamara Aleksic, Ruth Asher, et al. 2014. “Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling.” Cancer Research 74 (20): 5866–77. doi:10.1158/0008-5472.CAN-14-0806.